QrumPharma Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

QrumPharma General Information


Operator of a pharmaceutical company developing inhalation treatments for severe chronic and recurrent pulmonary infections. The company is developing a drug for the treatment of Nontuberculous Mycobacteria (NTM) and Tuberculosis.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Primary Office
  • 215 Decatur Street
  • Doylestown, PA 18901
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

QrumPharma Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore QrumPharma‘s full profile, request access.

Request a free trial